ORIGAMI THERAPEUTICS, INC.
San Diego, CA · Biotech · Private
Small molecule oral therapeutic that selectively degrades mutant huntingtin protein while sparing normal huntingtin in Huntington's disease
origamitherapeutics.com →- Grants
- $1.1M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Characterization of small molecules that lower mutant huntingtin protein as potential therapeutics for Huntington’s disease | $502,931 | |
| Federal grant | Department of Health and Human Services · Phase I · Characterization of small molecules that lower mutant huntingtin protein as potential therapeutics for Huntington’s disease | $107,065 | |
| Federal grant | Department of Health and Human Services · Phase I · Uncovering the molecular target(s) of ORI-113, a potential brain-penetrant small molecule therapeutic for Huntington's disease. | $499,988 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3171 | Chimagen Biosciences | — | — |
| 3172 | CHYNA, LLC | — | — |
| 3173 | XIRETSA INC. | — | — |
| 3174 | ORIGAMI THERAPEUTICS, INC. | — | — |
| 3175 | Claris Bio | — | — |
| 3176 | Haya Therapeutics | — | — |
| 3177 | Newleos | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.